APA (7th ed.) Citation

Huang, C., Fang, X., Mao, Y., Guo, R., Li, W., Xu, S., . . . Tang, L. (2022). Association of delayed chemoradiotherapy with elevated Epstein-Barr virus DNA load and adverse clinical outcome in nasopharyngeal carcinoma treatment during the COVID-19 pandemic: A retrospective study. Cancer cell international, 22(1), 1-8. https://doi.org/10.1186/s12935-022-02748-y

Chicago Style (17th ed.) Citation

Huang, Cheng-Long, Xue-Liang Fang, Yan-Ping Mao, Rui Guo, Wen-Fei Li, Si-Si Xu, Jun Ma, Lei Chen, and Ling-Long Tang. "Association of Delayed Chemoradiotherapy with Elevated Epstein-Barr Virus DNA Load and Adverse Clinical Outcome in Nasopharyngeal Carcinoma Treatment During the COVID-19 Pandemic: A Retrospective Study." Cancer Cell International 22, no. 1 (2022): 1-8. https://doi.org/10.1186/s12935-022-02748-y.

MLA (9th ed.) Citation

Huang, Cheng-Long, et al. "Association of Delayed Chemoradiotherapy with Elevated Epstein-Barr Virus DNA Load and Adverse Clinical Outcome in Nasopharyngeal Carcinoma Treatment During the COVID-19 Pandemic: A Retrospective Study." Cancer Cell International, vol. 22, no. 1, 2022, pp. 1-8, https://doi.org/10.1186/s12935-022-02748-y.